Thyrogen 0.9 MG vials
Ended Awarded
- Contract number
- SPE2DB25FVW63
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,367
Award facts
- Contract value 100% obligated
- $16,366.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,366.74 to AmerisourceBergen Drug Corp for the supply of Thyrogen 0.9 mg vials. This firm fixed-price, non-set-aside contract was awarded on May 30, 2025, with an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. The product being supplied—Thyrogen (recombinant human thyroid-stimulating hormone)—is a specialized pharmaceutical used in thyroid cancer management and diagnostic procedures within military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC vehicle enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company was competitively selected to serve as a prime pharmaceutical vendor, demonstrating its capability to fulfill specialized federal medical procurement requirements alongside other strategic contractors in DLA's Pharmaceutical Prime Vendor Global Program.
Quick answers
Who was awarded contract SPE2DB25FVW63?
SPE2DB25FVW63 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FVW63 worth?
The government has obligated $16,367 on SPE2DB25FVW63.
Is contract SPE2DB25FVW63 an order under another contract?
Yes. SPE2DB25FVW63 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FVW63 competed?
The extent of competition for SPE2DB25FVW63 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award